4/A

PRIMARY DOCUMENT

Company: Inhibitor Therapeutics, Inc.
Filed: March 23, 2004
Period of Report: March 12, 2004
Accession Number: 0001234066-04-000007

View Document ↗ View on SEC.gov ↗